Is STIM or SNWV more profitable?

Sanuwave Health has a net margin of 32.38% compared to Neuronetics' net margin of -19.62%. Sanuwave Health's return on equity of 1,728.10% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Neuronetics -19.62% -125.11% -22.15% Sanuwave Health 32.38% 1,728.10% 39.04%

Do analysts recommend INGN or SNWV?

Sanuwave Health has a consensus price target of $51.00, suggesting a potential upside of 975.95%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Is INGN or SNWV more profitable?

Sanuwave Health has a net margin of 32.38% compared to Inogen's net margin of -6.94%. Sanuwave Health's return on equity of 1,728.10% beat Inogen's return on equity. Company Net Margins Return on Equity Return on Assets Inogen -6.94% -13.17% -8.36% Sanuwave Health 32.38% 1,728.10% 39.04%

Which has preferable valuation & earnings, SNWV or OWLT?

Sanuwave Health has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sanuwave Health $44.05M 0.93 $11.81M $0.24 19.75 Owlet $105.70M 1.85 -$39.68M -$3.07 N/A

Is SNWV or OWLT more profitable?

Sanuwave Health has a net margin of 32.38% compared to Owlet's net margin of -8.61%. Sanuwave Health's return on equity of 1,728.10% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Sanuwave Health 32.38% 1,728.10% 39.04% Owlet -8.61% N/A -16.50%

Sanuwave Health (SNWV) Competitors

$4.74 -0.03 (-0.63%)

Closing price 04:00 PM Eastern

Extended Trading

$5.00 +0.26 (+5.38%)

As of 07:34 PM Eastern

Compare

SNWV vs. APYX, STIM, INGN, KRMD, and OWLT

Should you buy Sanuwave Health stock or one of its competitors? Sanuwave Health's main competitors and comparable companies include Apyx Medical (APYX), Neuronetics (STIM), Inogen (INGN), KORU Medical Systems (KRMD), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sanuwave Health compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

In the previous week, Apyx Medical had 19 more articles in the media than Sanuwave Health. MarketBeat recorded 20 mentions for Apyx Medical and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 0.42 beat Apyx Medical's score of -0.18 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Apyx Medical	Neutral
Sanuwave Health	Neutral

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market.

Apyx Medical presently has a consensus price target of $6.60, indicating a potential upside of 117.82%. Sanuwave Health has a consensus price target of $51.00, indicating a potential upside of 975.95%. Given Sanuwave Health's higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Sanuwave Health has a net margin of 32.38% compared to Apyx Medical's net margin of -14.78%. Sanuwave Health's return on equity of 1,728.10% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Sanuwave Health	32.38%	1,728.10%	39.04%

Sanuwave Health has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.42	-$11.21M	-$0.20	N/A
Sanuwave Health	$44.05M	0.93	$11.81M	$0.24	19.75

Summary

Sanuwave Health beats Apyx Medical on 9 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

53.6% of Neuronetics shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 8.4% of Neuronetics shares are held by company insiders. Comparatively, 14.4% of Sanuwave Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sanuwave Health has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	1.69	-$39M	-$0.54	N/A
Sanuwave Health	$44.05M	0.93	$11.81M	$0.24	19.75

Sanuwave Health has a net margin of 32.38% compared to Neuronetics' net margin of -19.62%. Sanuwave Health's return on equity of 1,728.10% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-19.62%	-125.11%	-22.15%
Sanuwave Health	32.38%	1,728.10%	39.04%

In the previous week, Neuronetics had 14 more articles in the media than Sanuwave Health. MarketBeat recorded 15 mentions for Neuronetics and 1 mentions for Sanuwave Health. Neuronetics' average media sentiment score of 0.61 beat Sanuwave Health's score of 0.42 indicating that Neuronetics is being referred to more favorably in the media.

Company	Overall Sentiment
Neuronetics	Positive
Sanuwave Health	Neutral

Neuronetics currently has a consensus price target of $4.50, indicating a potential upside of 36.36%. Sanuwave Health has a consensus price target of $51.00, indicating a potential upside of 975.95%. Given Sanuwave Health's higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Neuronetics has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market.

Summary

Sanuwave Health beats Neuronetics on 10 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Inogen?

Inogen (NASDAQ:INGN) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

Sanuwave Health has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.44	-$22.75M	-$0.90	N/A
Sanuwave Health	$44.05M	0.93	$11.81M	$0.24	19.75

89.9% of Inogen shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 2.5% of Inogen shares are held by insiders. Comparatively, 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sanuwave Health has a net margin of 32.38% compared to Inogen's net margin of -6.94%. Sanuwave Health's return on equity of 1,728.10% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Sanuwave Health	32.38%	1,728.10%	39.04%

In the previous week, Inogen had 4 more articles in the media than Sanuwave Health. MarketBeat recorded 5 mentions for Inogen and 1 mentions for Sanuwave Health. Inogen's average media sentiment score of 0.44 beat Sanuwave Health's score of 0.42 indicating that Inogen is being referred to more favorably in the media.

Company	Overall Sentiment
Inogen	Neutral
Sanuwave Health	Neutral

Sanuwave Health has a consensus price target of $51.00, suggesting a potential upside of 975.95%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Inogen has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market.

Summary

Sanuwave Health beats Inogen on 10 of the 15 factors compared between the two stocks.

How does Sanuwave Health compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

KORU Medical Systems presently has a consensus price target of $7.00, suggesting a potential upside of 105.88%. Sanuwave Health has a consensus price target of $51.00, suggesting a potential upside of 975.95%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, KORU Medical Systems had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 3 mentions for KORU Medical Systems and 1 mentions for Sanuwave Health. KORU Medical Systems' average media sentiment score of 0.54 beat Sanuwave Health's score of 0.42 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Positive
Sanuwave Health	Neutral

Sanuwave Health has a net margin of 32.38% compared to KORU Medical Systems' net margin of -4.03%. Sanuwave Health's return on equity of 1,728.10% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Sanuwave Health	32.38%	1,728.10%	39.04%

KORU Medical Systems has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market.

Sanuwave Health has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.80	-$2.64M	-$0.04	N/A
Sanuwave Health	$44.05M	0.93	$11.81M	$0.24	19.75

Summary

Sanuwave Health beats KORU Medical Systems on 10 of the 17 factors compared between the two stocks.

How does Sanuwave Health compare to Owlet?

Sanuwave Health (NASDAQ:SNWV) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

Sanuwave Health has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	0.93	$11.81M	$0.24	19.75
Owlet	$105.70M	1.85	-$39.68M	-$3.07	N/A

42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Comparatively, 36.2% of Owlet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Owlet had 7 more articles in the media than Sanuwave Health. MarketBeat recorded 8 mentions for Owlet and 1 mentions for Sanuwave Health. Owlet's average media sentiment score of 0.55 beat Sanuwave Health's score of 0.42 indicating that Owlet is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanuwave Health	Neutral
Owlet	Positive

Sanuwave Health currently has a consensus target price of $51.00, suggesting a potential upside of 975.95%. Owlet has a consensus target price of $15.00, suggesting a potential upside of 122.82%. Given Sanuwave Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Sanuwave Health is more favorable than Owlet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Sanuwave Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market. Comparatively, Owlet has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market.

Sanuwave Health has a net margin of 32.38% compared to Owlet's net margin of -8.61%. Sanuwave Health's return on equity of 1,728.10% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
Owlet	-8.61%	N/A	-16.50%

Summary

Sanuwave Health beats Owlet on 9 of the 17 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNWV vs. The Competition

Export

Metric	Sanuwave Health	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$41.02M	$5.95B	$7.06B	$13.10B
Dividend Yield	N/A	1.76%	2.57%	10.45%
P/E Ratio	19.75	26.22	269.06	25.28
Price / Sales	0.93	63.09	602.43	91.76
Price / Cash	2.81	33.92	70.48	50.90
Price / Book	14.81	6.10	12.91	6.24
Net Income	$11.81M	$148.67M	$3.45B	$347.60M
7 Day Performance	-19.39%	1.84%	1.12%	1.07%
1 Month Performance	-60.37%	4.56%	1.79%	1.03%
1 Year Performance	-87.45%	8.67%	67.69%	20.77%

Sanuwave Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNWV Sanuwave Health	2.9978 of 5 stars	$4.74 -0.6%	$51.00 +975.9%	-88.0%	$41.02M	$44.05M	19.75	40	Analyst Upgrade
APYX Apyx Medical	2.0544 of 5 stars	$4.05 -2.6%	$6.60 +63.0%	+29.4%	$169.74M	$58.42M	N/A	270	News Coverage Analyst Revision High Trading Volume
STIM Neuronetics	4.053 of 5 stars	$2.38 +5.8%	$4.00 +68.1%	-21.7%	$165.62M	$151.64M	N/A	180	Earnings Report Analyst Forecast
INGN Inogen	1.2586 of 5 stars	$6.05 -6.8%	N/A	-24.5%	$163.80M	$348.67M	N/A	1,030	High Trading Volume
KRMD KORU Medical Systems	3.8941 of 5 stars	$3.55 -0.3%	$7.00 +97.2%	-22.6%	$163.06M	$45.11M	N/A	80	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNWV) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sanuwave Health (SNWV) Competitors

SNWV vs. APYX, STIM, INGN, KRMD, and OWLT

How does Sanuwave Health compare to Apyx Medical?

Summary

How does Sanuwave Health compare to Neuronetics?

Summary

How does Sanuwave Health compare to Inogen?

Summary

How does Sanuwave Health compare to KORU Medical Systems?

Summary

How does Sanuwave Health compare to Owlet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sanuwave Health (SNWV) Competitors

SNWV vs. APYX, STIM, INGN, KRMD, and OWLT

How does Sanuwave Health compare to Apyx Medical?

Does the media favor APYX or SNWV?

Do institutionals and insiders believe in APYX or SNWV?

Which has more risk & volatility, APYX or SNWV?

Do analysts recommend APYX or SNWV?

Is APYX or SNWV more profitable?

Which has better earnings and valuation, APYX or SNWV?

Summary

How does Sanuwave Health compare to Neuronetics?

Do institutionals & insiders believe in STIM or SNWV?

Which has higher valuation & earnings, STIM or SNWV?

Is STIM or SNWV more profitable?

Does the media favor STIM or SNWV?

Do analysts prefer STIM or SNWV?

Which has more risk & volatility, STIM or SNWV?

Summary

How does Sanuwave Health compare to Inogen?

Which has stronger valuation & earnings, INGN or SNWV?

Do institutionals and insiders have more ownership in INGN or SNWV?

Is INGN or SNWV more profitable?

Does the media favor INGN or SNWV?

Do analysts recommend INGN or SNWV?

Which has more risk and volatility, INGN or SNWV?

Summary

How does Sanuwave Health compare to KORU Medical Systems?

Do institutionals and insiders have more ownership in KRMD or SNWV?

Do analysts prefer KRMD or SNWV?

Does the media favor KRMD or SNWV?

Is KRMD or SNWV more profitable?

Which has more volatility and risk, KRMD or SNWV?

Which has better valuation & earnings, KRMD or SNWV?

Summary

How does Sanuwave Health compare to Owlet?

Which has preferable valuation & earnings, SNWV or OWLT?

Do insiders and institutionals have more ownership in SNWV or OWLT?

Does the media refer more to SNWV or OWLT?

Do analysts recommend SNWV or OWLT?

Which has more risk and volatility, SNWV or OWLT?

Is SNWV or OWLT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools